Rejection, Transplant Active Not Recruiting Phase Trials for Alemtuzumab (DB00087)

Also known as: Graft Rejection / Transplant rejections / Transplant Rejection / Transplanted organ rejection (disorder) / Graft rejection (finding) / Complication of transplanted organ (disorder)

IndicationStatusPhase
DBCOND0030946 (Rejection, Transplant)Active Not RecruitingNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00619528HLA-Identical Sibling Renal Transplant ToleranceTreatment